Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06063928 · ClinicalTrials.gov registry record · NA

Confronting Cancer as a Community

A NA study of Colorectal Carcinoma, sponsored by University of Southern California.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
2
Study locations

NCT06063928: Recruiting NA study of Colorectal Carcinoma, sponsored by University of Southern California.

NCT06063928 is a NA study of Colorectal Carcinoma that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 500 participants, below the 1,087-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (54% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06063928, a NA study of Colorectal Carcinoma, is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
2
Study locations

Study Summary

This study aims to better understand the cause of colorectal cancer and how to find the best treatment for Hispanic patients with colorectal cancer. The genetic information in the blood and tissues may explain why patients who have the same type of cancer and receive the same treatment do not always have the same results. By combining genetic (certain qualities or traits passed from parents to offspring) information with clinical data, such as the responses of different kinds of cancers to different treatments, this study could lead to more knowledge about why certain cancers occur and why they respond differently to treatments. Information gathered from this study may help researchers match treatments to the genetics of each patient and the genetic changes in their tumor. This approach is known as personalized medicine.

Primary Outcome

Determined from time of registration to date of documented event such as treatment-related deaths, second same or other primary cancers, and deaths from other cancers.

Conditions Studied

Interventions

  • OTHER Usual Care Educational Materials
  • OTHER Intervention Educational Materials

Study Locations (2)

California

  • Los Angeles County-USC Medical Center - Los Angeles
  • USC / Norris Comprehensive Cancer Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2022-05-25
Est. Completion 2028-05-25
Phase NA
University of Southern California

617 total trials

What NCT06063928 shows while recruiting

NCT06063928 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,087-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (54% lower).

The record links to 1 condition, with Colorectal Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Usual Care Educational Materials is the first listed.

NCT06063928 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06063928 about?

NCT06063928 is a clinical study titled "Confronting Cancer as a Community". This study aims to better understand the cause of colorectal cancer and how to find the best treatment for Hispanic patients with colorectal cancer. The genetic information in the blood and tissues may explain why patients who have the same type of cancer and receive the same treatment do not always...

What is the current status of trial NCT06063928?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2022-05-25. Estimated completion is 2028-05-25.

What conditions does trial NCT06063928 study?

This clinical trial studies the following conditions: Colorectal Carcinoma.

What interventions are being tested in trial NCT06063928?

The interventions under investigation include: Usual Care Educational Materials (OTHER), Intervention Educational Materials (OTHER).

Who is sponsoring clinical trial NCT06063928?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06063928 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06063928's enrollment target sits among peer trials

500 13th of 53 higher than 41 of 53 other Colorectal Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06063928, the US trial registry maintained by the National Library of Medicine. NCT06063928 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.